SCHEMBL21379296

SCHEMBL21379296

O=C(Oc1ccc(CI)cc1)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 1/20 0.59
KMT2A Q03164 13/20 0.56
MAPT P10636 5/20 0.56
TDP1 Q9NUW8 3/20 0.56
ALDH1A1 P00352 2/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
PKM P14618 1/20 0.56
MEN1 O00255 3/20 0.54
RAB9A P51151 1/20 0.53
SMN1; SMN2 Q16637 2/20 0.49
CASP3 P42574 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
HSD17B10 Q99714 1/20 0.47
KDM4E B2RXH2 1/20 0.47
GAA P10253 1/20 0.47
CTSL P07711 1/20 0.46
NSD2 O96028 1/20 0.46
SLC6A2 P23975 1/20 0.46
SLC6A3 Q01959 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19924698 0.87 PARP10 (0.61) PARP10KMT2AMAPTTDP1ALDH1A1
SCHEMBL12199140 0.85 PARP10 (0.62) PARP10KMT2AMAPTTDP1ALDH1A1
SCHEMBL725405 0.84 PARP10 (0.77) PARP10KMT2AMAPTTDP1ALDH1A1
SCHEMBL19777378 0.84 MEN1 (0.53) PARP10KMT2AMAPTMEN1RAB9A
SCHEMBL10608864 0.84 PARP10 (0.61) PARP10KMT2AMAPTTDP1ALDH1A1
SCHEMBL8210785 0.84 PARP10 (0.61) PARP10KMT2AMAPTTDP1ALDH1A1
SCHEMBL4905240 0.84 KMT2A (0.62) PARP10KMT2AMAPTTDP1ALDH1A1
SCHEMBL1546405 0.84 PARP10 (0.61) PARP10KMT2AMAPTTDP1ALDH1A1
SCHEMBL9663679 0.82 PARP10 (0.81) PARP10KMT2AMAPTTDP1ALDH1A1
Hydrochloric Acid SCHEMBL16050040 0.82 PARP10 (0.74) PARP10KMT2AMAPTTDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190292215-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE SPEROVIE BIOSCIENCES, INC. 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292215-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE STING1, CGAS, MYD88 PARP10 1806/4885KMT2A 4445/4885MAPT 3525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.